Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

300

To be discontinued: 2 (1%)
Discontinued: 298 (99%)
Reversed: 0 (0%)

Late reports

362 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-05-09 223862
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999
ACT NABILONE 0.5MG CAPSULE Resolved 2020-04-16 2021-09-23 112394
ACT NABILONE 0.5MG CAPSULE Resolved 2019-12-19 2020-03-12 101740
ACT NABILONE 1MG CAPSULE Resolved 2019-12-19 2020-03-12 101730
ACT NABILONE 0.5MG CAPSULE Resolved 2020-07-16 2020-08-07 120459
ACT NABILONE 1MG CAPSULE Resolved 2019-10-17 2020-03-12 96733
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99965
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99968
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-17 2018-06-15 3357
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-06-15 10972
ACT OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-10-11 10975
TEVA-OLMESARTAN 20MG TABLET Resolved 2018-10-22 2020-06-11 65350
TEVA-OLMESARTAN 40MG TABLET Resolved 2018-10-22 2020-06-11 65340
TEVA-OLMESARTAN / HCTZ 12.5MG 20MG TABLET Resolved 2018-10-22 2020-06-11 65343
TEVA-OLMESARTAN / HCTZ 25MG 40MG TABLET Resolved 2018-10-22 2020-06-11 65346
TEVA-OLMESARTAN / HCTZ 12.5MG 40MG TABLET Resolved 2018-09-12 2020-06-11 61359
ACT OLOPATADINE 0.1% 0.1% SOLUTION Actual shortage 2018-10-23 2018-10-23 65519

Showing 181 to 200 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DEFERASIROX 250MG TABLET FOR SUSPENSION Discontinued 2020-01-21 2020-01-21 103796
TEVA-DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Discontinued 2025-03-20 2025-03-20 253156
TEVA-DICLOFENAC EC 25MG TABLET (ENTERIC-COATED) Discontinued 2024-01-25 2024-01-26 217254
TEVA-DICLOFENAC EC 50MG TABLET (ENTERIC-COATED) Discontinued 2025-04-25 2025-04-25 255812
TEVA-DICLOFENAC SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2025-04-29 2025-04-29 256131
TEVA-DICLOFENAC-K 50MG TABLET Discontinued 2025-03-20 2025-03-20 253168
TEVA-DILTIAZEM CD 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81307
TEVA-DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-06-04 2019-06-04 85572
TEVA-DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-06-04 2019-06-04 85575
TEVA-DIVALPROEX 125MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97232
TEVA-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97235
TEVA-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97238
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117491
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117494
TEVA-ECTOSONE 0.1% LOTION Discontinued 2023-12-05 2023-12-05 212526
TEVA-EFAVIRENZ 600MG TABLET Discontinued 2025-04-29 2025-04-29 256134
TEVA-ENALAPRIL 8MG TABLET Discontinued 2018-10-19 2018-10-19 64855
TEVA-ENALAPRIL 8MG TABLET Discontinued 2018-10-19 2018-10-19 64858
TEVA-ENALAPRIL 8MG TABLET Discontinued 2018-10-19 2018-10-19 64861
TEVA-ENALAPRIL 16MG TABLET Discontinued 2018-10-19 2018-10-19 64866

Showing 161 to 180 of 300